AVT32-DRL_PB (pembrolizumab biosimilar) / Alvotech, Dr. Reddy’s - LARVOL DELTA

Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda in Participants With Fully Resected Melanoma (clinicaltrials.gov) - P1 | N=120 | Recruiting | Sponsor: Alvotech Swiss AG | Not yet recruiting ➔ Recruiting

Enrollment open • Cutaneous Melanoma • Melanoma • Oncology • Solid Tumor